Sarah Brookes1, Sherry Voytik-Harbin1,2, Hongji Zhang3, Stacey Halum3. 1. Department of Basic Medical Sciences, Purdue University, West Lafayette, Indiana, U.S.A. 2. Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana, U.S.A. 3. Department of Speech, Language and Hearing Sciences, Purdue University, West Lafayette, Indiana, U.S.A.
Abstract
OBJECTIVE: There is an unmet need for tissue-engineered three-dimensional (3D) muscle constructs for laryngeal reconstruction. Functional engineered muscle could be used to repair postoncologic or traumatic defects or to medialize the vocal fold in cases of paresis/paralysis. Autologous, organized, engineered muscle that has adequate bulk integrates into host tissue and restores function currently does not exist. METHODS: Primary skeletal muscle progenitor cells (MPCs) were isolated from F344 rats. Three-dimensional muscle constructs were created by encapsulating MPCs via flow alignment in a customized collagen formulation and cultured under passive tension. Muscle-specific immunohistochemistry and confocal microscopy were used to evaluate muscle tissue differentiation. After 2 weeks of culture, muscle constructs were implanted into surgically created defects in the rat larynx. Postmortem function testing and histology was performed at 1 and 3 months. RESULTS: Immunohistochemistry with confocal microscopy demonstrated well-differentiated myotubes, which were well aligned and distributed throughout the engineered construct in vitro. There was evidence of restoration of normal laryngeal function at 1 month postoperative, as indicated by safe swallow (no aspiration events), weight gain, and excellent animal survival. Postmortem specimens demonstrated functional muscle contraction on ex vivo testing, and histology confirmed integration into host tissue. CONCLUSION: This is the first study to demonstrate that functional, 3D tissue-engineered skeletal muscle can be developed from primary MPCs and standardized oligomeric collagen. Collectively, these findings may have tremendous clinical implications for autologous laryngeal muscle repair and reconstruction. LEVEL OF EVIDENCE: NA. Laryngoscope, 128:603-609, 2018.
OBJECTIVE: There is an unmet need for tissue-engineered three-dimensional (3D) muscle constructs for laryngeal reconstruction. Functional engineered muscle could be used to repair postoncologic or traumatic defects or to medialize the vocal fold in cases of paresis/paralysis. Autologous, organized, engineered muscle that has adequate bulk integrates into host tissue and restores function currently does not exist. METHODS: Primary skeletal muscle progenitor cells (MPCs) were isolated from F344 rats. Three-dimensional muscle constructs were created by encapsulating MPCs via flow alignment in a customized collagen formulation and cultured under passive tension. Muscle-specific immunohistochemistry and confocal microscopy were used to evaluate muscle tissue differentiation. After 2 weeks of culture, muscle constructs were implanted into surgically created defects in the rat larynx. Postmortem function testing and histology was performed at 1 and 3 months. RESULTS: Immunohistochemistry with confocal microscopy demonstrated well-differentiated myotubes, which were well aligned and distributed throughout the engineered construct in vitro. There was evidence of restoration of normal laryngeal function at 1 month postoperative, as indicated by safe swallow (no aspiration events), weight gain, and excellent animal survival. Postmortem specimens demonstrated functional muscle contraction on ex vivo testing, and histology confirmed integration into host tissue. CONCLUSION: This is the first study to demonstrate that functional, 3D tissue-engineered skeletal muscle can be developed from primary MPCs and standardized oligomeric collagen. Collectively, these findings may have tremendous clinical implications for autologous laryngeal muscle repair and reconstruction. LEVEL OF EVIDENCE: NA. Laryngoscope, 128:603-609, 2018.
Authors: Caroline Rhim; Dorothy A Lowell; Mary C Reedy; Dorothy H Slentz; Sarah J Zhang; William E Kraus; George A Truskey Journal: Muscle Nerve Date: 2007-07 Impact factor: 3.217
Authors: Carlo A Rossi; Michela Pozzobon; Andrea Ditadi; Karolina Archacka; Annalisa Gastaldello; Marta Sanna; Chiara Franzin; Alberto Malerba; Gabriella Milan; Mara Cananzi; Stefano Schiaffino; Michelangelo Campanella; Roberto Vettor; Paolo De Coppi Journal: PLoS One Date: 2010-01-01 Impact factor: 3.240
Authors: David O Sohutskay; Kevin P Buno; Sunil S Tholpady; Samantha J Nier; Sherry L Voytik-Harbin Journal: Regen Med Date: 2020-03-31 Impact factor: 3.806
Authors: Clarissa Hernandez Stephens; Kara S Orr; Anthony J Acton; Sarah A Tersey; Raghavendra G Mirmira; Robert V Considine; Sherry L Voytik-Harbin Journal: Am J Physiol Endocrinol Metab Date: 2018-06-12 Impact factor: 4.310
Authors: Clarissa Hernandez Stephens; Rachel A Morrison; Madeline McLaughlin; Kara Orr; Sarah A Tersey; J Catharine Scott-Moncrieff; Raghavendra G Mirmira; Robert V Considine; Sherry Voytik-Harbin Journal: Am J Physiol Endocrinol Metab Date: 2020-06-16 Impact factor: 4.310